May 6, 2020
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Alnylam Pharmaceuticals
December 10, 2018
Alnylam, Silence settle on royalties on Onpattro in EU, dismiss court proceedings
Silence Therapeutics and Alnylam Pharmaceuticals have settled for royalty on net sales of Onpattro in EU, the companies said in separate press releases Monday, noting they will dismiss court proceedings